Similarity in pharmacokinetics of oseltamivir and oseltamivir carboxylate in Japanese and Caucasian subjects.
作者： Jerome J. Schentag , George Hill , Tom Chu , Craig R. Rayner
关键词: Oseltamivir 、 Ethnic difference 、 Oseltamivir carboxylate 、 Influenza a 、 Significant difference 、 Placebo 、 Body weight 、 Pharmacology 、 Pharmacokinetics 、 Medicine
摘要: … Although the pharmacokinetics of oseltamivir has been … -to-head comparisons of the pharmacokinetics in Japanese and … the pharmacokinetic properties of oseltamivir and oseltamivir …
sci-hub.se 参考文章(30)
C M Machado, L S V Boas, A V A Mendes, I F da Rocha, D Sturaro, F L Dulley, C S Pannuti, Use of Oseltamivir to control influenza complications after bone marrow transplantation. Bone Marrow Transplantation. ,vol. 34, pp. 111- 114 ,(2004) , 10.1038/SJ.BMT.1704534
Charles Oo, George Hill, Albert Dorr, Baolian Liu, Samuel Boellner, Penelope Ward, Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1-5 years. European Journal of Clinical Pharmacology. ,vol. 59, pp. 411- 415 ,(2003) , 10.1007/S00228-003-0639-6
Sharon Marsh, Ming Xiao, Jinsheng Yu, Ranjeet Ahluwalia, Matthew Minton, Robert R. Freimuth, Pui-Yan Kwok, Howard L. McLeod, Pharmacogenomic assessment of carboxylesterases 1 and 2 Genomics. ,vol. 84, pp. 661- 668 ,(2004) , 10.1016/J.YGENO.2004.07.008
Tomoe Fujita, Chaline Brown, Elaine J. Carlson, Travis Taylor, Melanie de la Cruz, Susan J. Johns, Doug Stryke, Michiko Kawamoto, Kazumi Fujita, Richard Castro, Chung-Wen Chen, Emil T. Lin, Claire M. Brett, Esteban Gonzalez Burchard, Thomas E. Ferrin, Conrad C. Huang, Maya K. Leabman, Kathleen M. Giacomini, Functional analysis of polymorphisms in the organic anion transporter, SLC22A6 (OAT1). Pharmacogenetics and Genomics. ,vol. 15, pp. 201- 209 ,(2005) , 10.1097/01213011-200504000-00003
John J. Treanor, Frederick G. Hayden, Peter S. Vrooman, Rick Barbarash, Robert Bettis, Dennis Riff, Sudeep Singh, Nelson Kinnersley, Penelope Ward, Roger G. Mills, for the US Oral Neuraminidase Study Group, Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza JAMA. ,vol. 283, pp. 1016- 1024 ,(2000) , 10.1001/JAMA.283.8.1016
Catia Marzolini, Rommel G Tirona, Richard B Kim, Pharmacogenomics of the OATP and OAT families Pharmacogenomics. ,vol. 5, pp. 273- 282 ,(2004) , 10.1517/PHGS.5.3.273.29831
Noriharu SHIJUBO, Gen YAMADA, Mamoru TAKAHASHI, Tetsuya TOKUNOH, Takashi SUZUKI, Shosaku ABE, Experience with oseltamivir in the control of nursing home influenza A outbreak. Internal Medicine. ,vol. 41, pp. 366- 370 ,(2002) , 10.2169/INTERNALMEDICINE.41.366
Robert Welliver, Effectiveness of Oseltamivir in Preventing Influenza in Household ContactsA Randomized Controlled Trial JAMA. ,vol. 285, pp. 748- 754 ,(2001) , 10.1001/JAMA.285.6.748
Frederick G. Hayden, Robert L. Atmar, Margo Schilling, Casey Johnson, Donald Poretz, David Paar, Les Huson, Penelope Ward, Roger G. Mills, Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. The New England Journal of Medicine. ,vol. 341, pp. 1336- 1343 ,(1999) , 10.1056/NEJM199910283411802
Laurent Kaiser, Cynthia Wat, Tracy Mills, Paul Mahoney, Penelope Ward, Frederick Hayden, Impact of Oseltamivir Treatment on Influenza-Related Lower Respiratory Tract Complications and Hospitalizations Archives of Internal Medicine. ,vol. 163, pp. 1667- 1672 ,(2003) , 10.1001/ARCHINTE.163.14.1667